INmune Bio Inc. announced that Edgardo (Ed) Baracchini, Ph.D., has joined the company's board of directors. Dr. Baracchini has an impressive biotech business development background with over 25 years of experience in structuring and negotiated research and development partnerships, mergers, acquisitions and licensing agreements. He has negotiated over 80 business transactions with multinational pharmaceutical firms, biotechnology companies and prominent universities which resulted in transactions valued in excess of $5.3 billion. He currently serves on the board of 4D Pharma PLC, as was previously Chief Business Officer of Xencor Inc. Prior to this, Dr. Baracchini was associated with Metabasis Therapeutics, where he quickly moved from the role of Vice President to Senior Vice President of Business Development.